APP and Alzheimer disease: Among these, the amyloid cascade hypothesis (Hardy and Higgins, 1992) —which posits that abnormal amyloid precursor protein (APP) processing leads to excessive β-amyloid (Aβ) peptide accumulation, plaque formation, and subsequent neuronal dysfunction—has guided AD research and drug development for over three decades.